The Emerging Companies Section serves the needs of small to medium size BIO member companies most of whom do not yet have major products approved and on the market. This section has its own governing body and fills one-third of the seats on the board of directors. This section operates to bring their opinion to bear on major issues affecting smaller companies, and to construct programs to enhance their development.
Staff Contact: Alan Eisenberg
|
|
Chairman
Rachel K. King, MBA
President & CEO
GlycoMimetics, Inc
|
Vice Chairman - ECS
Ron Cohen, MD
President & CEO
Acorda Therapeutics, Inc
|
Member
Donald Beeman
Chief Executive Officer
LigoCyte Pharmaceuticals, Inc
|
Member
Alexis Borisy
Founder, President, CEO (former)
CombinatoRx, Incorporated
|
Member
Geoffrey F. Cox, PhD
Chairman, President & CEO
GTC Biotherapeutics, Inc
|
Member
John F. Crowley, JD, MBA
President and CEO
Amicus Therapeutics, Inc
|
Member
J. Donald deBethizy, PhD
President & CEO
Targacept, Inc
|
Member
Douglas A. Doerfler
President & CEO
MaxCyte, Inc
|
Member
Paul H. Fischer, PhD
President & CEO
GenVec, Inc
|
Member
Mitchell H. Gold, M.D.
President, CEO & Director
Dendreon Corporation
|
Member
Maxine Gowen, PhD
President & CEO
Trevena, Inc.
|
Member
David F. Hale
Chairman
Micromet, Inc
|
Member
Paul J. Hastings
President & CEO
OncoMed Pharmaceuticals, Inc
|
Member
Russell H. Herndon
President & CEO
Hydra Biosciences, Inc
|
Member
Steven H. Holtzman
Chairman & CEO
Infinity Pharmaceuticals, Inc
|
Member
Vaughn M. Kailian
Managing Director
MPM Capital, LLP
|
Member
Perry Karsen
Chief Executive Officer
Pearl Therapeutics, Inc
|
Member
Mark Kessel, JD
Managing Director
Symphony Capital LLC
|
Member
Scott Koenig, MD, PhD
President & CEO
MacroGenics, Inc
|
Member
Tracy Lefteroff
Global Leader, Life Sciences Industry Services
PricewaterhouseCoopers, LLP
|
Member
John Maraganore, PhD
Chief Executive Officer
Alnylam Pharmaceuticals, Inc
|
Member
Thomas P. Mathers
President & CEO
Peptimmune, Inc
|
Member
Gordon C. McCauley
President & CEO
Allon Therapeutics, Inc
|
Member
Russell M. Medford, MD, PhD
President & CEO
Salutria Pharmaceuticals, LLC
|
Member
Alan C. Mendelson, JD
Partner & Co-Chair, Emerging Companies Practice Group
Latham & Watkins, LLP
|
Member
Steven J. Mento, PhD
President, CEO & Co-Founder
Conatus Pharmaceuticals, Inc
|
Member
Arlene M. Morris
President & CEO
Affymax, Inc
|
Member
Dan Myers
Co-Founder, President & CEO
Alimera Sciences, Inc
|
Member
Lita Nelsen
Director, Technology Licensing Office
Massachusetts Institute of Technology
|
Member
Thomas B. Okarma, PhD, MD
President, CEO & Director
Geron Corporation
|
Member
Jeffrey M. Ostrove, PhD
President & CEO
Ceregene, Inc
|
Member
Deepa Pakianathan, PhD
General Partner, Biotechnology
Delphi Ventures
|
Member
Kristine Peterson
Chief Executive Officer
Valeritas, Inc
|
Member
Dennis J. Purcell, MBA
Senior Managing Partner
Aisling Capital LLC
|
Member
Timothy C. Rodell, MD
Chief Executive Officer & President
GlobeImmune, Inc
|
Member
Arthur T. Sands, MD, PhD
President & CEO
Lexicon Pharmaceuticals, Inc
|
Member
James Sapirstein, MBA
President & CEO
Tobira Therapeutics, Inc
|
Member
Gail Schulze
CEO
Zosano Pharmaceutical, Inc
|
Member
Mark W. Schwartz, PhD
President & CEO (former)
Bayhill Therapeutics, Inc
|
Member
Christy L. Shaffer, PhD
President & CEO
Inspire Pharmaceuticals, Inc
|
Member
Laura Shawver, PhD
Chief Executive Officer
Phenomix Corporation
|
Member
Stephen A. Sherwin, MD
Chairman
Ceregene, Inc
|
Member
Peter A. Thompson, MD
Co-Founder
Trubion Pharmaceuticals, Inc
|
Member
Eric Tomlinson, PhD, DSc
President & CEO
Altea Therapeutics Corporation
|
Member
Gil Van Bokkelen, PhD
Chairman & CEO
Athersys, Inc
|
Member
Harold E. Van Wart, PhD
President, CEO & Director
Metabolex, Inc
|
Member
Bradford A. Zakes, MBA
Chief Executive Officer
Cerevast Therapeutics, Inc
|
Member
Robert Zerbe, MD
Chief Executive Officer & Founder
QuatRx Pharmaceuticals, Inc
|
Printer Friendly